Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new blog series, researchers in the OxImmnuo Literature initiative select papers that cover topics in COVID-19 research that they think may be of interest to the wider public and summarise them for a more general audience

Stack of academic papers with text highlighted and a pen resting on top

The OxImmuno Literature initiative has collected together a team of around 100 researchers from the Medical Sciences Division of the University of Oxford to read, review and summarise recent COVID-19 research from all round the world in order to support the researchers working on COVID-19 here at the University of Oxford.

Research papers are peer reviewed, ie. read and checked by other scientists, before they are published in research journals. As COVID-19 is such a new phenomenon most of the research has not yet had time to be peer reviewed but, in order to help other scientists working on COVID-19, research is still made available as a pre-print for other researchers to read.

Our summaries of some of these pre-prints and papers can be read here. However, these are written for other researchers. We have selected a few papers that cover topics in COVID-19 research that we think may be of interest to the wider public and have summarised them for a more general audience and included more background information. These summaries, with links to the original research, can be found in this, our new blog.

The blogs are available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal

Awards and Appointments Coronavirus COVID-19 General Innovation Research

Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.